Business Context and Reporting Period
This Form 8-K Current Report was filed by Spruce Biosciences, Inc. on December 2, 2022, covering events occurring on November 28, 2022, and December 1, 2022. The Company, an emerging growth company incorporated in Delaware, reported the termination of its existing principal executive office lease and the execution of a new lease agreement for its headquarters.
Key Financial Metrics and Agreements
The filing details specific financial terms related to real estate agreements rather than operational performance metrics such as revenue or profit.
- New Lease Commencement: January 1, 2023, for 6,496 square feet in South San Francisco, CA.
- New Lease Term: 62 months with an option to extend for an additional three years.
- New Lease Cost: Initial annual base rent of approximately $0.3 million, subject to 3% annual increases. The Company is also responsible for its share of operating and tax expenses.
- Lease Termination Fee: The Landlord agreed to pay the Company a termination fee of $0.6 million.
- Letter of Credit Return: The Landlord agreed to return an existing Letter of Credit of approximately $0.2 million.
The filing text does not provide clear values for revenue, net income, operating cash flow, gross margins, total debt, or liquidity positions.
Material Changes Versus Prior Period
The primary material change is the relocation of the Company's principal executive offices. The Company terminated its prior lease at 2001 Junipero Serra Boulevard, Daly City, effective December 31, 2022, citing changing market conditions in the commercial real estate sector. This action accelerates the expiration of the prior lease term and results in a net cash inflow from the termination fee and return of the Letter of Credit, offset by future rental obligations under the new agreement.
Outlook, Risks, and Management Commentary
Management indicated that the lease termination was driven by changing market conditions within the commercial real estate market. The new lease agreement includes a three-year extension option, providing flexibility for future space requirements. No specific forward-looking financial guidance, risk factors, or contingencies beyond the standard lease obligations were disclosed in this report.
Investor Verification Checklist
- Verify the receipt of the $0.6 million termination fee and the $0.2 million Letter of Credit return within the specified business days following December 31, 2022.
- Confirm the actual move-in date and commencement of rent payments for the new South San Francisco location on January 1, 2023.
- Review the full text of the New Lease (Exhibit 10.1) and Lease Termination Agreement (Exhibit 10.2) for additional covenants or conditions not summarized in the 8-K.
- Assess the impact of the new lease's annual 3% rent escalators and operating expense obligations on future cash flow projections.